PEDIATRICS Vol. 97 No. 4 April 1996, pp. 601
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ment, L. R.
Right arrow Articles by Allan, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ment, L. R.
Right arrow Articles by Allan, W. C.

Antenatal Exposure to Steroids and the Additional Prophylaxis Effect of Indomethacin to Prevent Intraventricular Hemorrhage

Laura R. Ment MD1, William Oh MD2, Richard A. Ehrenkranz MD3, and Walter C. Allan MD4

1 Department of Pediatrics and Neurology, Yale University School of Medicine, New Haven, CT 06520
2 Department of Pediatrics Brown University School of Medicine Providence, RI 02905
3 Departments of Pediatrics and Obstetrics & Gynecology, Yale University School of Medicine, New Haven, CT 06520
4 Maine Neurology Portland, ME 04102

Following the publication of our multicenter randomized indomethacin intraventricular hemorrhage (IVH) prevention trial in Pediatrics,1 we received numerous queries concerning our protocol outcome variables. None was more intriguing to us, however, than the question of David Braun, MD, who asked what additional protective effect might be offered by the early administration of indomethacin to those infants who had been exposed to antenatal steroid administration and had no evidence of IVH at 6 hours postnatal age.